a nationally-recognized commercialization leader, is the Senior Advisor, Innovation & Economic Development at CWRU.  Jankowski is active in corporate-level governance, having served as a founding or current board member and trustee for a myriad of entrepreneurial enterprises, including Arteriocyte, BioEnterprise Corporation, Folio Photonics, JumpStart, Neuros Medical, and RoadPrintz.  He has contributed leadership to multiparty innovation, institutional investment, and economic development programs that include the Case Coulter Translational Research Partnership, NIH CTSA Key Functions Committee, NSF SBIR Program and TeamNEO Business Development Council. 

In 2013, Jankowski was appointed as Case Western Reserve University’s first Chief Innovation Officer.  In this capacity, he was a leader of - and contributor to - innovation occurring throughout the University.  In 2018, Jankowski co-founded the Pathway in Health Entrepreneurship and Innovation at the Case School of Medicine to prepare MD students for career-long innovative contributions.  Prior to this position, Joe was the leader of the University’s technology transfer and commercialization activities.  Under his direction for nearly a decade, the tech transfer function evaluated nearly 2,000 invention disclosures, enacted more than 300 commercial licenses and option agreements, and established 35 spin-off enterprises.  

Jankowski is an active contributor to healthcare innovation, currently serving as a retained advisor to Baptist Health South Florida Innovations, Henry Ford Health Systems Innovations and Tampa General Hospital.  He was a member of the inaugural Cleveland Clinic Innovations program, which he joined following a role as a technology analyst at Battelle Memorial Institute.  

Jankowski holds a Ph.D. in Chemistry from SUNY ESF, an MBA from the Weatherhead School of Management and a dual bachelor degrees in Chemical Process and Environmental Engineering Technologies from the University of Dayton.